| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Sunshine Biopharma Inc.
13G
SBFM · 867781809
|
6.0%
Checked 5% or less
|
10/14/2026
Event 10/8/2026
|
|||
|
C1 Fund Inc.
13G/A
Amendment 2
12686Q100
|
8/18/2026
Event 8/18/2026
|
||||
| BJI Financial Group | |||||
| BJI Financial Group | |||||
|
C1 Fund Inc.
13G
12686Q100
|
6.1% |
5/13/2026
Event 5/8/2026
|
|||
| BJI Financial Group | 6.1% | ||||
| BJI Financial Group | 6.1% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.